CURIS, INC. Research and Development in Process
CURIS, INC. (CRIS) reported Research and Development in Process of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2018-03-08
- CURIS, INC. research and development in process for the quarter ending 2017-12-31 was $0.00.
- CURIS, INC. research and development in process for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. research and development in process for the quarter ending 2016-12-31 was $0.00.
- CURIS, INC. research and development in process for the quarter ending 2016-09-30 was $17.99M.
- CURIS, INC. research and development in process for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CURIS, INC. research and development in process for fiscal 2016 was $17.99M, a 26.12% decline from fiscal 2015.
- CURIS, INC. research and development in process for fiscal 2015 was $24.35M.
- CURIS, INC. research and development in process for fiscal 2014 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 6 month as first filed | Research and Development in Process 9 month | Research and Development in Process 9 month as first filed | Research and Development in Process 12 month | Research and Development in Process 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $17.99M derived: sum of 2 quarters · filed 2018-03-08 | $17.99M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $17.99M 10-Q · filed 2017-11-07 | $17.99M 10-Q · filed 2017-11-07 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $185.00 derived: sum of 3 quarters · filed 2018-03-08 | $24.35M 10-K · filed 2018-03-08 | $24.35M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $185.00 derived: sum of 2 quarters · filed 2016-11-03 | $24.35M 10-Q · filed 2016-11-03 | $24.35M 10-Q · filed 2015-11-09 | |||
| 2015-06-30 | $185.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $24.35M 10-Q · filed 2016-08-04 | $24.35M 10-Q · filed 2015-08-06 | ||||
| 2015-03-31 | $24.35M 10-Q · filed 2016-05-09 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 | ||||||
| 2012-12-31 | $9.50M 10-K · filed 2014-03-13 | $9.50M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |